106 related articles for article (PubMed ID: 16956652)
1. S1P regulation of ovarian carcinoma invasiveness.
Smicun Y; Reierstad S; Wang FQ; Lee C; Fishman DA
Gynecol Oncol; 2006 Dec; 103(3):952-9. PubMed ID: 16956652
[TBL] [Abstract][Full Text] [Related]
2. Lysophospholipids increase interleukin-8 expression in ovarian cancer cells.
Schwartz BM; Hong G; Morrison BH; Wu W; Baudhuin LM; Xiao YJ; Mok SC; Xu Y
Gynecol Oncol; 2001 May; 81(2):291-300. PubMed ID: 11330965
[TBL] [Abstract][Full Text] [Related]
3. S1P and LPA have an attachment-dependent regulatory effect on invasion of epithelial ovarian cancer cells.
Smicun Y; Gil O; Devine K; Fishman DA
Gynecol Oncol; 2007 Nov; 107(2):298-309. PubMed ID: 17716713
[TBL] [Abstract][Full Text] [Related]
4. Biochemical regulation of breast cancer cell expression of S1P2 (Edg-5) and S1P3 (Edg-3) G protein-coupled receptors for sphingosine 1-phosphate.
Dolezalova H; Shankar G; Huang MC; Bikle DD; Goetzl EJ
J Cell Biochem; 2003 Mar; 88(4):732-43. PubMed ID: 12577307
[TBL] [Abstract][Full Text] [Related]
5. S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac.
Devine KM; Smicun Y; Hope JM; Fishman DA
Gynecol Oncol; 2008 Aug; 110(2):237-45. PubMed ID: 18513786
[TBL] [Abstract][Full Text] [Related]
6. Characterization of lysophosphatidic acid and sphingosine-1-phosphate-mediated signal transduction in rat cortical oligodendrocytes.
Yu N; Lariosa-Willingham KD; Lin FF; Webb M; Rao TS
Glia; 2004 Jan; 45(1):17-27. PubMed ID: 14648542
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine 1-phosphate receptor expression profile in human gastric cancer cells: differential regulation on the migration and proliferation.
Yamashita H; Kitayama J; Shida D; Yamaguchi H; Mori K; Osada M; Aoki S; Yatomi Y; Takuwa Y; Nagawa H
J Surg Res; 2006 Jan; 130(1):80-7. PubMed ID: 16183075
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells.
Yamaguchi H; Kitayama J; Takuwa N; Arikawa K; Inoki I; Takehara K; Nagawa H; Takuwa Y
Biochem J; 2003 Sep; 374(Pt 3):715-22. PubMed ID: 12803545
[TBL] [Abstract][Full Text] [Related]
9. Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin.
González-Díez M; Rodríguez C; Badimon L; Martínez-González J
Thromb Haemost; 2008 Jul; 100(1):119-26. PubMed ID: 18612546
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine 1-phosphate induces Mcl-1 upregulation and protects multiple myeloma cells against apoptosis.
Li QF; Wu CT; Guo Q; Wang H; Wang LS
Biochem Biophys Res Commun; 2008 Jun; 371(1):159-62. PubMed ID: 18423379
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine 1-phosphate (S1P) induces shape change in rat C6 glioma cells through the S1P2 receptor: development of an agonist for S1P receptors.
Kim K; Kim YL; Sacket SJ; Kim HL; Han M; Park DS; Lee BK; Lee WK; Ha HJ; Im DS
J Pharm Pharmacol; 2007 Jul; 59(7):1035-41. PubMed ID: 17637200
[TBL] [Abstract][Full Text] [Related]
12. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling.
Fisher KE; Pop A; Koh W; Anthis NJ; Saunders WB; Davis GE
Mol Cancer; 2006 Dec; 5():69. PubMed ID: 17156449
[TBL] [Abstract][Full Text] [Related]
13. Receptor-mediated activation of a Cl(-) current by LPA and S1P in cultured corneal keratocytes.
Wang J; Carbone LD; Watsky MA
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3202-8. PubMed ID: 12356825
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine 1-phosphate mediates proliferation and survival of mesoangioblasts.
Donati C; Cencetti F; Nincheri P; Bernacchioni C; Brunelli S; Clementi E; Cossu G; Bruni P
Stem Cells; 2007 Jul; 25(7):1713-9. PubMed ID: 17464089
[TBL] [Abstract][Full Text] [Related]
15. Regulation of volume-sensitive osmolyte efflux from human SH-SY5Y neuroblastoma cells following activation of lysophospholipid receptors.
Heacock AM; Dodd MS; Fisher SK
J Pharmacol Exp Ther; 2006 May; 317(2):685-93. PubMed ID: 16415087
[TBL] [Abstract][Full Text] [Related]
16. MMP-1-PAR1 axis mediates LPA-induced epithelial ovarian cancer (EOC) invasion.
Wang FQ; Fisher J; Fishman DA
Gynecol Oncol; 2011 Feb; 120(2):247-55. PubMed ID: 21093894
[TBL] [Abstract][Full Text] [Related]
17. IL-6 and IL-8 release is mediated via multiple signaling pathways after stimulating dendritic cells with lysophospholipids.
Oz-Arslan D; Rüscher W; Myrtek D; Ziemer M; Jin Y; Damaj BB; Sorichter S; Idzko M; Norgauer J; Maghazachi AA
J Leukoc Biol; 2006 Aug; 80(2):287-97. PubMed ID: 16769764
[TBL] [Abstract][Full Text] [Related]
18. LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2).
So J; Wang FQ; Navari J; Schreher J; Fishman DA
Gynecol Oncol; 2005 Jun; 97(3):870-8. PubMed ID: 15919106
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
Walter DH; Rochwalsky U; Reinhold J; Seeger F; Aicher A; Urbich C; Spyridopoulos I; Chun J; Brinkmann V; Keul P; Levkau B; Zeiher AM; Dimmeler S; Haendeler J
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):275-82. PubMed ID: 17158356
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion.
Wang FQ; Smicun Y; Calluzzo N; Fishman DA
Mol Cancer Res; 2006 Nov; 4(11):831-41. PubMed ID: 17114341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
